Literature DB >> 15236857

The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK.

J Maudsley1, S P Stone, C C Kibbler, S R Iliffe, S J Conaty, B D Cookson, G J Duckworth, A Johnson, P G Wallace.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) predominantly affects those over 65 years old. There may be a substantial pool of older people with MRSA in the community. We studied the prevalence in one London general practice, screening 258 older people living in their own home. MRSA (E-MRSA 15) was found in two participants (0.78%). Past history of MRSA was the only significant risk factor. The results of this and other studies suggest that national guidelines recommending early discharge for MRSA carriers have not resulted in widespread community acquisition amongst elderly people living in their own home. Community antibiotic policies for skin and soft-tissue infection do not require amendment. Patients with previous MRSA should be isolated and screened on admission especially to high-risk units.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236857     DOI: 10.1016/j.jhin.2004.03.023

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  15 in total

1.  MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.

Authors:  David H Wyllie; Tim E A Peto; Derrick Crook
Journal:  BMJ       Date:  2005-09-09

2.  Improving surveillance of MRSA bacteraemia.

Authors:  Georgia Duckworth; Andr Charlett
Journal:  BMJ       Date:  2005-10-29

3.  MRSA carriage.

Authors:  Sarah Smyth
Journal:  Br J Gen Pract       Date:  2008-02       Impact factor: 5.386

4.  Prevalence of MRSA colonization in an adult urban Indian population undergoing orthopaedic surgery.

Authors:  Sanjay Agarwala; Dnyanesh Lad; Vikas Agashe; Anshul Sobti
Journal:  J Clin Orthop Trauma       Date:  2015-09-11

5.  Oral and Topical Antibiotics for Clinically Infected Eczema in Children: A Pragmatic Randomized Controlled Trial in Ambulatory Care.

Authors:  Nick A Francis; Matthew J Ridd; Emma Thomas-Jones; Christopher C Butler; Kerenza Hood; Victoria Shepherd; Charis A Marwick; Chao Huang; Mirella Longo; Mandy Wootton; Frank Sullivan
Journal:  Ann Fam Med       Date:  2017-03       Impact factor: 5.166

6.  Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies.

Authors:  Kunihiro Inai; Hiromichi Iwasaki; Sakon Noriki; Satoshi Ikegaya; Masanori Yamashita; Yoshiaki Imamura; Nobuo Takimoto; Hisataka Kato; Takanori Ueda; Hironobu Naikia
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

7.  Financial implications of plans to combat methicillin-resistant Staphylococcus aureus (MRSA) in an orthopaedic department.

Authors:  K Hassan; C Koh; D Karunaratne; C Hughes; S N Giles
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

8.  Staphylococcus aureus Colonization in Patients Undergoing Total Hip or Knee Arthroplasty and Cost-effectiveness of Decolonization Programme.

Authors:  Hosseinali Hadi; Mahmmud Jabalameli; Abolfazl Bagherifard; Ehsanollah Ghaznavi-Rad; Ahmadreza Behrouzi; Ali Joorabchi; Amir Azimi
Journal:  Arch Bone Jt Surg       Date:  2018-11

Review 9.  Staphylococcal enterotoxins.

Authors:  Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  Toxins (Basel)       Date:  2010-08-18       Impact factor: 4.546

10.  Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom.

Authors:  Verena Schneider-Lindner; J A Delaney; Sandra Dial; Andre Dascal; Samy Suissa
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.